Active	Status	Sponsor type	Region	Phase	Filter
14 Active 10 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

14 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Grunstein, Ron
SURMOUNT-OSA, NCT05412004: Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea	Completed	3	469	Europe, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Sleep Apnea, Obesity	03/24	03/24
TRIUMPH-2, NCT05929079: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight	Active, not recruiting	3	1000	Europe, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Type 2 Diabetes, Obesity, Overweight, Obstructive Sleep Apnea	05/26	05/26
CANREST, NCT05253417: The CANabidiol Use for RElief of Short Term Insomnia	Completed	2	208	RoW	50 mg Cannabidiol (CBD), BodECS BioAbsorb(TM) capsule, Placebo, 100 mg Cannabidiol (CBD)	Bod Australia, Woolcock Institute of Medical Research	Sleep Disturbance, Insomnia, Insomnia Type; Sleep Disorder, Insomnia, Transient, Insomnia Due to Anxiety and Fear, Insomnia Due to Other Mental Disorder	07/23	07/23
ACTRN12605000689673: An initial factorial evaluation of the potential synergy between two novel agents (CB0011 and CB0012) for the treatment of Obstructive Sleep Apnea Syndrome	Not yet recruiting	1/2	100			Cypress Bioscience, Inc, Cypress Biosince Inc.	Obstructive Sleep Apnea Syndrome
Mela-Nia, NCT06801379: A Novel Inhaled Formulation of Melatonin to Treat Adults with Insomnia: Pharmacokinetic Study	Not yet recruiting	1	5	RoW	Inhaled Melatonin (100 μg), Melatonin, N-Acetyl-5-methoxytryptamine, Oral Melatonin (4 mg), Circadin	Woolcock Institute of Medical Research	Insomnia	12/25	05/26
Mela-Nia, NCT06802913: A Novel Inhaled Formulation of Melatonin to Treat Adults with Insomnia: Efficacy Study	Not yet recruiting	1	10	RoW	Inhaled Melatonin (100 μg), Melatonin, Oral Melatonin (4 mg), N-Acetyl-5-methoxytryptamine, Circadin	Woolcock Institute of Medical Research	Insomnia	12/25	05/26
SUCCEED, NCT05568381: Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention	Completed	N/A	40	RoW	digital CBT-I, Sleepio, Online Sleep Health Education package	University of Sydney	Cognitive Dysfunction, Insomnia, Mild Cognitive Impairment, Cognitive Disorder, Sleep Wake Disorders	08/23	11/23
Restless, NCT06567210: The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders	Not yet recruiting	N/A	110	RoW	CBCTi, General sleep information	Woolcock Institute of Medical Research, Macquarie University, Australia	Insomnia Chronic, Depression, Anxiety	06/27	06/29
Hoyos, Camilla
ACTRN12619000876190: Melatonin Supplementation in Mild Cognitive Impairment.	Completed	2	40			Woolcock Institute of Medical Research, National Health Medical and Research Council	Mild Cognitive Impairment
CANREST, NCT05253417: The CANabidiol Use for RElief of Short Term Insomnia	Completed	2	208	RoW	50 mg Cannabidiol (CBD), BodECS BioAbsorb(TM) capsule, Placebo, 100 mg Cannabidiol (CBD)	Bod Australia, Woolcock Institute of Medical Research	Sleep Disturbance, Insomnia, Insomnia Type; Sleep Disorder, Insomnia, Transient, Insomnia Due to Anxiety and Fear, Insomnia Due to Other Mental Disorder	07/23	07/23
CUPID, NCT05344170: Cannabinol Use in Patients With Insomnia Disorder	Completed	1/2	20	RoW	30 mg Cannabinol (CBN), ECS 310 (1.5%), 300 mg Cannabinol (CBN), ECS 310 (15%), Placebo	Woolcock Institute of Medical Research, University of Sydney	Insomnia Disorder	08/23	09/23
SUCCEED, NCT05568381: Sleep Disturbance in MCI: A Study of a Cognitive Behavioural Therapy Digital Intervention	Completed	N/A	40	RoW	digital CBT-I, Sleepio, Online Sleep Health Education package	University of Sydney	Cognitive Dysfunction, Insomnia, Mild Cognitive Impairment, Cognitive Disorder, Sleep Wake Disorders	08/23	11/23
Restless, NCT06567210: The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders	Not yet recruiting	N/A	110	RoW	CBCTi, General sleep information	Woolcock Institute of Medical Research, Macquarie University, Australia	Insomnia Chronic, Depression, Anxiety	06/27	06/29
Birling, Yoann
ACTRN12619000140156: Investigation of the efficacy and safety of Zao Ren An Shen (ZRAS) capsule for chronic insomnia	Recruiting	N/A	90			Western Sydney University, NICM Health Research Institute, Western Sydney University	chronic insomnia